Livia
Livia, a brand of Israel-based iPulse Medical Ltd., develops and sells an FDA-cleared, patented wearable device using SmartWave micro-pulse technology to provide drug-free menstrual pain relief to women worldwide, distributed via direct-to-consumer e-commerce and select international partners.
- Company typePrivate
- Founded2016
- HeadquartersKfar Saba, Israel
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What Livia does
Livia (legally iPulse Medical Ltd., incorporated in Israel) is a women's health medical device company that develops, markets, and sells a wearable, drug-free system for menstrual pain relief. The company was commercially launched in 2016 and is headquartered in Israel, with a US returns facility in Oxnard, California, and returns processing support in Hong Kong. As of the source period, Livia operates with a small team of 1-10 employees and reports that 250,000+ devices have been sold across 120+ countries.
The core product is the Livia device, built on the company's patented SmartWave technology, which delivers electronic micro-pulses to leverage the body's Gate Control pain inhibition mechanism. The device is FDA-cleared as a Class 2a medical instrument and additionally holds CE marking for Europe and Health Canada clearance. Clinical validation rests on three studies, including a double-blind, multi-site, randomized controlled trial with p<0.0001 significance, a 28.1-point reduction on the VAS pain scale, and reported 86-90% relief rates. The product line is complemented by consumable and accessory SKUs including 40cm and 60cm flower pad variants, replacement gel pads, and decorative Skins.
Livia's business model combines one-time device sales (Standard Kit priced at $129, down from a $199 list price) with a recurring subscription plan ($29 entry plus $8/month billed semi-annually) that bundles automatic gel pad refills, lifetime warranty, and free product upgrades every three years. Go-to-market is product-led direct-to-consumer e-commerce via mylivia.com, supplemented by a UK distribution partnership with First Trade Limited, an affiliate ambassador program, content marketing, and substantial social media presence (151k+ Facebook, 71k+ Instagram followers, 43m+ YouTube views). The company has achieved 12,532+ reviews with an average 4.2/5 rating, indicating a broad, distributed consumer base rather than institutional concentration.
Livia firmographics
Firmographics- Name
- Livia
- Legal name
- iPulse Medical Ltd.
- Website
- https://mylivia.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Livia, a brand of Israel-based iPulse Medical Ltd., develops and sells an FDA-cleared, patented wearable device using SmartWave micro-pulse technology to provide drug-free menstrual pain relief to women worldwide, distributed via direct-to-consumer e-commerce and select international partners.
- Ownership category
- akta.pro rank
Livia industry classification
Industry- Product category
- Women's Health Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Pain Relief & Anti-Inflammatory (Analgesics) (HLAIADAA)
- akta.pro secondary industry
- Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)
Keywords
Where Livia is headquartered
LocationHeadquarters
- HQ city
- Kfar Saba
- HQ country
- Israel
- HQ region
- Middle East
Offices3 records
Markets served
Livia business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Operations, Technology or R&D, Personnel, Infrastructure
Revenue model
- Device Sales: One-time purchase of Livia device. Standard Kit at $129 (original $199). Includes device, flower pads, gel pads, charging cable, and carrying case.
- Subscription Plan: Premium Subscription at $29 start, then $8/mo billed every 6 months. Includes ongoing gel pad supplies, extended warranty, free product upgrades, and VIP support.
- Accessories and Consumables: Replacement gel pads, flower pads in various colors, decorative skins for device customization ($12-$22 range).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Standard Kit - One-time purchase for $129 |
| Subscription | Multi-year contract | Premium Subscription - $29 start, then $8/mo |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels9 records
Livia product offering
Product offeringCore offering
Livia develops and sells a wearable, FDA-cleared menstrual pain relief device that uses its patented SmartWave™ micro-pulse technology to block pain signals without drugs. The core device is complemented by consumable replacement gel pads and electrode flower pads, decorative device Skins, and an ongoing Subscription Plan that ships automatic gel refills and includes a lifetime warranty and device upgrades.
Product overview
Livia offers a focused portfolio of women's health products centered on its core SmartWave™ menstrual pain relief device. The main offering is a compact, wearable TENS-style device that uses electronic micro-pulses to block period pain. This core device is complemented by consumable accessories including Flower Pads (electrode pads in standard 40cm and extended 60cm wire options), Gel Pads (replacement pads with 6-month supply option), and decorative Skins (multiple designs available). The company also offers a Subscription Plan that bundles the device with ongoing gel pad supplies, extended warranty, and automatic product upgrades, providing a recurring revenue model for long-term customer engagement.
Differentiator
Problem solved
Functional benefit
Products and services
- Livia Menstrual Pain Relief Device A compact, FDA-cleared, reusable wearable device that delivers patented SmartWave™ electronic micro-pulses to block menstrual pain signals. Sold to women aged 16+ as a drug-free, non-hormonal alternative to painkillers.
- Livia Flower Pads (40 cm) Electrode pads with attached gel pads and a 40 cm wire for standard placement on the lower abdomen or back when using the Livia device.
- Livia Flower Pads — Long Wire (60 cm) Extended 60 cm wire electrode pads for users who need greater placement flexibility or alternative positioning with the Livia device.
- Livia Gel Pads (6-Month Supply) Replacement gel pads for the Livia device intended to be renewed monthly for optimal performance and hygiene; a 6-month supply is sold as a single SKU.
- Livia Skins (decorative covers) Interchangeable decorative covers for the Livia device available in multiple designs (Classic, Wood, Pillow, Flower, Fractal, Water) and colors for personal style customization.
- Livia Subscription Plan Recurring service bundling the Livia device with ongoing gel pad refills shipped automatically every 6 months, lifetime warranty covering device and accessories, and free product upgrades.
Quantifiable outcome
- 90% of women reported pain relief (first prototype study)
- +4 more outcomes
Companies that use Livia
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles2 records
Livia technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Livia partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- First Trade LimitedcoreOfficial UK distributor for Livia products. Enables customers in the UK to purchase directly with fast delivery and no import duties or customs fees.
Scale indicators9 records
Recent moves8 records
Expansion highlights4 records
Livia competitors and assessment
Company assessmentDirect peers
- iTENS: Wireless TENS device maker selling app-controlled electrotherapy units for pain relief, directly competing with Livia in the wearable TENS category at comparable price points via DTC and Amazon.
- Aleve Direct Therapy: Bayer's OTC TENS device marketed for back and muscle pain; the closest direct competitor combining a consumer pain-relief brand with a wearable electrotherapy unit sold through retail and online.
Others
- ThermaCare: OTC heat-therapy patch brand (Angelini/Church & Dwight) widely used for menstrual cramp relief; not a device competitor but a substitute solution for the same primary use case Livia addresses.
- Hatch: Women's wellness brand offering products across fertility, postpartum, and menopause; adjacent rather than directly competing, but targets a similar premium female consumer demographic and lifestyle category.
Emerging players
- TechCare: DTC TENS/EMS device maker selling rechargeable electronic pulse massagers on Amazon; competes with Livia on electrotherapy mechanism and consumer pain-relief positioning at lower price points.
- Pure Enrichment: DTC wellness brand selling pain relief and relaxation devices (massagers, heating pads) direct to consumers; competes with Livia for the same women's wellness buyer in adjacent product categories.
Broad incumbents
- Omron Healthcare: Large incumbent medical device company offering TENS units (e.g., Omron Pocket Pain Pro) for OTC pain relief through pharmacy and retail; competes with Livia on category breadth and distribution scale.
- Elvie: Well-funded women's health wearable brand (breast pumps, pelvic floor trainers) targeting the same premium femtech consumer; comparable brand-led DTC motion and women's health category positioning.
- Beurer: Established German medical device manufacturer offering a wide TENS/EMS product line alongside broader health monitoring devices; competes in the same electrotherapy pain-relief category as Livia with greater retail distribution.
- Compex: Global TENS/EMS brand known for muscle stimulation and pain management devices used by athletes and consumers; overlaps with Livia's electrotherapy mechanism and consumer pain-relief positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Livia social profiles
Digital presenceLivia compliance and trust
Trust signalCompliance3 records
Livia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Livia leadership team
Management profileNumber of profiles
Profiles2 records
Livia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Livia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Livia
What does Livia do?
Livia develops and sells a wearable, FDA-cleared menstrual pain relief device that uses its patented SmartWave™ micro-pulse technology to block pain signals without drugs. The core device is complemented by consumable replacement gel pads and electrode flower pads, decorative device Skins, and an ongoing Subscription Plan that ships automatic gel refills and includes a lifetime warranty and device upgrades.
Is Livia a public or private company?
Livia is a private company. It is classified as corporate owned and is currently operating.
When was Livia founded?
Livia was founded in 2016. It employs 1 to 10 people.
Where is Livia based?
Livia is headquartered in Kfar Saba, Israel, in the Middle East region.
How does Livia make money?
Three revenue lines are on record. Device Sales are the primary driver. The others are subscription Plan and accessories and Consumables.
Who are Livia's main competitors?
Direct peers on record are iTENS and Aleve Direct Therapy. Others are ThermaCare and Hatch. Emerging players are TechCare and Pure Enrichment. Broad incumbents are Omron Healthcare, Elvie, Beurer and Compex.
Does Livia have an API?
No public API is recorded for Livia.
What industry is Livia in?
Livia's product category is Women's Health Medical Devices. Its primary akta.pro industry code is HLAIADAA, Pain Relief & Anti-Inflammatory (Analgesics), with a secondary code of HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring. Its NAICS code is 339112 and its SIC code is 3845.